How many subsidiaries does Canopy Growth Corp file with the SEC?

17, listed in its most recent exhibit 21. They are incorporated across 7 jurisdictions, led by Canada, Australia, Germany. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is Canopy Growth Corp financially healthy?

Canopy Growth Corp scores 4 out of 9 on the Piotroski F-score. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of Canopy Growth Corp?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are MORGAN STANLEY (trimming), CITADEL ADVISORS LLC (trimming), RENAISSANCE TECHNOLOGIES LLC. Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

Canopy Growth Corp (CGC)

Nasdaq · Medicinal Chemicals & Botanical Products

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

medical marijuana company based in Smiths Falls, Ontario

Corporate structure

17 entities across 7 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-06-15 — see the exhibit.

Which other public companies file entities in the same places:

Canada8 Delaware3 Germany2 Australia1 Netherlands1 Poland1 California1

Subsidiaries of Canopy Growth Corp as disclosed in its SEC filing
Entity	Jurisdiction	Note
Canada Inc.	Canada
Apollo Applied Research Inc.	Canada
Canopy Growth Australia PTY Ltd.	Australia
Canopy Growth Germany GmbH	Germany
Canopy Growth Holdings B.V.	Netherlands
Canopy Growth LATAM Holdings Corporation	Canada
Canopy Growth Polska Sp. Z. o. o.	Poland
Canopy Growth USA, LLC	Delaware
EB Transaction Corp.	Delaware
EB Transaction Sub I LLC	Delaware
IsoCanMed Inc.	Canada
Montréal Cannabis Medical Inc.	Canada
MTL Cannabis Corp.	Canada
Storz & Bickel America, Inc.	California
Storz & Bickel GmbH	Germany
The Supreme Cannabis Company, Inc.	Canada
Tweed Leasing Corp.	Canada

Financial health

Two standard screens, computed from the XBRL in FY2026 against FY2025. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

4 / 9

FAILReturn on assets positiveROA -23.5%
FAILOperating cash flow positiveOCF -64M
PASSReturn on assets improving-65.2% → -23.5%
PASSCash flow exceeds earningsOCF -64M vs NI -263M
PASSLong-term debt ratio falling32.7% → 19.4% of assets
PASSCurrent ratio improving3.12 → 3.34
FAILNo share dilution108M → 298M shares
FAILGross margin improving29.6% → 24.5%
FAILAsset turnover improving0.29× → 0.25×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2022	—	—	—	—	—
FY2022	—	—	—	—	—
FY2023	$402.9M	−$3.3B	−$566.8M	-25.8%	463,724,414
FY2024	$297.1M	−$657.3M	−$285.4M	27.2%	74,787,521
FY2025	$269.0M	−$598.1M	−$176.6M	29.6%	107,553,729
FY2026	$284.6M	−$262.9M	−$69.1M	24.5%	298,043,044

Ownership flow

5 institutions tracked — 1 added, 3 reduced, 1 opened a new position.

Institutional holders of Canopy Growth Corp and their share-count change
Manager	Kind	Shares	Change	Value
CITADEL ADVISORS LLC	Hedge fund	1,786,444	−1,450,884	$1.7B
MORGAN STANLEY	Active fund	1,946,294	−23,346	$1.8B
BlackRock, Inc.	Index	586	−155	$557,000
JPMORGAN CHASE & CO	Active fund	521	+124	$518,000

RENAISSANCE TECHNOLOGIES LLC holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.

From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.

Identity

CIK: 0001737927
SIC: 2833 · Medicinal Chemicals & Botanical Products
Incorporated: Canada (Federal Level)
Headquarters: SMITH FALLS, Ontario, Canada
Founded: 2013-00-00

Ownership

Institutional: 8.0%
Institutions: 252
Insiders: 0.2%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other medicinal chemicals & botanical products companies

Canopy Growth Corp files under SIC 2833 — all 8 medicinal chemicals & botanical products companies compared on assets and F-score.

Trulieve Cannabis Corp.TRLV Cronos Group Inc.CRON Ascend Wellness Holdings, Inc.AAWH USANA HEALTH SCIENCES INCUSNA Jushi Holdings Inc.JUSH Niagen Bioscience, Inc.NAGE

Dealer positioning — end of day

Where dealer gamma sat in CGC’s option chain after the close on 2026-09-01, aggregated from the full chain. This is a once-a-day snapshot, not a live read — 88 contracts.

Net gamma (per 1% move): $88,377.475
Call wall: 1.50
Spot at capture: 1.00

Computed from the listed option chain by my own aggregation, once, after the close — it describes where positioning sat that evening and does not update through the next session. The version that rebuilds per strike while the market is open is the intraday gamma product. Not investment advice.

Questions about Canopy Growth Corp

How many subsidiaries does Canopy Growth Corp file with the SEC?: 17, listed in its most recent exhibit 21. They are incorporated across 7 jurisdictions, led by Canada, Australia, Germany. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is Canopy Growth Corp financially healthy?: Canopy Growth Corp scores 4 out of 9 on the Piotroski F-score. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of Canopy Growth Corp?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are MORGAN STANLEY (trimming), CITADEL ADVISORS LLC (trimming), RENAISSANCE TECHNOLOGIES LLC. Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.